Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors

Endocan expression has been reported to be associated with aggressive tumor progression and poor outcomes in various cancers, such as breast cancer, renal cell cancer, lung cancer, gastric cancer, and pituitary adenomas. However, the prognostic significance of endocan in neuroendocrine tumors remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Liang-Yu, Yeh, Yi-Chen, Chu, Chia-Huei, Won, Justin G.S., Shyr, Yi-Ming, Chao, Yee, Li, Chung-Pin, Wang, Shin-E, Chen, Ming-Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662320/
https://www.ncbi.nlm.nih.gov/pubmed/29019897
http://dx.doi.org/10.1097/MD.0000000000008262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662320/
https://www.ncbi.nlm.nih.gov/pubmed/29019897
http://dx.doi.org/10.1097/MD.0000000000008262

Ejemplares similares